Figure 1

ELISA-based analysis of Abs reactivity against human, viral and MAP-derived peptides in RA, NMOSD and HCs. The sera were tested against plate-coated IL-26ā20KK (B), IL-256ā70 (A), IRF5424ā434 (C), BOLF1305ā320 (D), Herv-Kenv19ā37 (E) and MAP_402718ā32 (F) peptides. Bars represent the medianā±āinterquartile range. Thresholds for Abs positivity are indicated by dashed lines. Percentages of Abs prevalence respective to each group, AUC and P-values are indicated above the distributions.